MedCity News
JANUARY 28, 2025
Quibims technology applies artificial intelligence analysis to medical images to detect biomarkers. Hospitals and biopharma companies are among the startups customers, using its technology to analyze images to detect disease and guide clinical trial enrollment. The post Medtech Startup Quibim Corrals $50M to Advance AI Analysis in Medical Imaging appeared first on MedCity News.
PharmaVoice
JANUARY 28, 2025
As changes to the U.S. regulatory foundation take hold, pharmas need to change their strategies to keep innovation — and the bottom line — above the surface.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedCity News
JANUARY 28, 2025
It’s a place where compassion and dignity are paramount, where patients and families find solace and support during the most challenging times. We owe it to them to ensure that hospice care is of the highest quality, accessible to all and integrated into the broader continuum of care. The post We Need to Talk About Hospice appeared first on MedCity News.
Eversana Intouch
JANUARY 28, 2025
In a rapidly evolving industry, staying ahead of the curve is critical. In PM360 ‘s article, What Is Pharma Marketing in 2025 ? Angela Tenuta, President, Full-Service Agencies, delves into the transformative trends shaping the future of pharmaceutical marketing. Applied AI Although AI promises a great return on investment, the pharma industry has been slow to adopt it due to ethical, regulatory, and compliance hurdles.
Advertiser: ZoomInfo
AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.
MedCity News
JANUARY 28, 2025
The structure of Atalanta Therapeutics RNA interference drugs enables them to distribute broadly and deeply into brain tissue. Lead programs for Huntingtons disease and a rare inherited form epilepsy are on track to enter the clinic this year. The post RNAi Biotech Atalanta Unveils $97M to Reach the Clinic in Two Rare Neuro Diseases appeared first on MedCity News.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
JANUARY 28, 2025
The MedTech industry has demonstrated remarkable resilience in navigating uncertainty, and 2025 promises to be a pivotal year as the election supercycle concludes and AI regulatory frameworks become clearer. The post 10 Key MedTech Themes for 2025 appeared first on MedCity News.
PharmaTimes
JANUARY 28, 2025
Patients and care partners may find once every four weeks maintenance dosing easier
MedCity News
JANUARY 28, 2025
According to the National Community Pharmacists Association, 60.4% of independent pharmacists are weighing not stocking one or more of the first 10 drugs in the Medicare Drug Price Negotiation program. Another 32.8% have already decided not to stock one or more of the drugs. The post Many Community Pharmacists Wont Carry Drugs in Medicare Negotiation Program, NCPA Warns appeared first on MedCity News.
pharmaphorum
JANUARY 28, 2025
Quibim has raised $50 million in first-round financing to support the rollout of its AI biomarkers for use in the analysis of medical imaging.
Speaker: Jesse Hunter and Brynn Chadwick
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
PharmaTimes
JANUARY 28, 2025
Phase 3 trial of Descartes-08 in myasthenia gravis to start in 1H25
Pharmaceutical Technology
JANUARY 28, 2025
AB2 Bio has made an option and licensing agreement with Nippon Shinyaku, granting the latter the option to commercialise Tadekinig alfa.
Pharmacy Times
JANUARY 28, 2025
The new indication for semaglutide adds to the long list of conditions that the GLP-1 receptor agonist has been approved for, and provides a new option for high-risk patients with these chronic conditions.
pharmaphorum
JANUARY 28, 2025
Veru's obesity candidate achieved the objective of preserving muscle in people taking weight-loss drug Wegovy, but its share price still fell sharply.
Advertiser: ZoomInfo
ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!
PharmaTech
JANUARY 28, 2025
The deal is being made for an all-cash price of $250 million, but with an additional $752.5 million available in potential milestone payments.
pharmaphorum
JANUARY 28, 2025
Sage Therapeutics has unanimously rejected Biogen's acquisition offer of around $469 million, saying it "significantly undervalues" the company.
Pharmaceutical Technology
JANUARY 28, 2025
the company announced that its Phase III trial examining its gastroenteropancreatic tumour treatment, ITM-11, met its primary endpoint.
pharmaphorum
JANUARY 28, 2025
Regulators have started reviews of GSK's depemokimab, aiming to become the first drug for asthma that can be dosed twice a year.
Speaker: Kevin Burke
AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.
Pharmaceutical Technology
JANUARY 28, 2025
A year after reducing half of its workforce, Allakos will downsize to just 15 employees as it halts the development of AK006.
Pharmaceutical Commerce
JANUARY 28, 2025
A study explores dual-enrollment in these planscompared to other Medicare Advantage plans impacts North Carolinas Medicaid fee-for-service spending.
Pharmaceutical Technology
JANUARY 28, 2025
Metsera is aiming to put its weight loss drug MET-097i, which boasts of a longer half-life, through Phase III trials.
Pharmacy Times
JANUARY 28, 2025
Endocrine therapy in combination with CDK4/6 inhibitors improves patients outcomes, but many still become treatment resistant.
Advertiser: ZoomInfo
Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.
Pharmaceutical Technology
JANUARY 28, 2025
Can-Fite BioPharma has secured a US patent for Namodenoson, its lead drug candidate, for use as an anti-obesity treatment.
pharmaphorum
JANUARY 28, 2025
Enhertu gets much-anticipated new FDA approval in breast cancer that expands its label and makes it an earlier option in the treatment pathway.
Pharmaceutical Technology
JANUARY 28, 2025
Arena Internationals Outsourcing in Clinical Trials West Coast 2025 will discuss patient centricity, diversity, and regulatory shifts.
Pharmaceutical Commerce
JANUARY 28, 2025
Starting May 27, 2025, the FDAs DSCSA enforcement will require all supply chain stakeholders to implement and test serialization and tracking processes to meet compliance.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Pharmaceutical Technology
JANUARY 28, 2025
Sages board of directors said that the proposal significantly undervalues the company and is not in the best interest of shareholders.
PharmExec
JANUARY 28, 2025
Gregory Mattingly, MD, president, Midwest Research Group, founding partner, St. Charles Psychiatric Associates, discusses the approval of Spravato for treatment-resistant depression.
Pharmaceutical Technology
JANUARY 28, 2025
This study reinforces the significance of intensive glycaemic control and is a paradigm shift in managing the disease and its complications.
Expert insights. Personalized for you.
293 
Let's personalize your content